Meinhard Wlaschek Selected Research

Meinhard Wlaschek Research Topics

Disease

11	Wounds and Injuries (Trauma) 01/2022 - 09/2005
6	Inflammation (Inflammations) 01/2019 - 09/2005
5	Neoplasms (Cancer) 01/2020 - 11/2002
4	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2013 - 08/2006
3	Mitochondrial Diseases (Mitochondrial Disease) 09/2023 - 01/2017
3	Cicatrix (Scar) 01/2020 - 04/2009
3	Premature Aging 01/2020 - 07/2002
2	Leg Ulcer 01/2019 - 03/2011
2	Dermatitis 01/2018 - 12/2013
2	Skin Diseases (Skin Disease) 07/2008 - 04/2008
2	Hyperoxia 11/2003 - 10/2002
1	Diabetic Foot 01/2022
1	Ulcer 01/2022
1	Leukocyte-Adhesion Deficiency Syndrome 01/2020
1	Iron Overload 01/2019
1	Seborrheic Dermatitis 01/2018
1	Melanoma (Melanoma, Malignant) 09/2017
1	Nevus (Nevi) 09/2017
1	Vasculitis (Vasculitides) 01/2016
1	Fibrosis (Cirrhosis) 02/2014
1	Weight Loss (Weight Reduction) 04/2011
1	Osteoporosis 04/2011
1	Kyphosis 04/2011
1	Atrophy 04/2011
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2009
1	Arthritis (Polyarthritis) 04/2008

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 09/2023 - 10/2005
5	IntegrinsIBA 01/2020 - 08/2006
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 11/2002
3	Superoxide DismutaseIBA 01/2016 - 11/2002
2	Ficusin (Psoralen)IBA 01/2020 - 11/2003
2	IronIBA 01/2019 - 03/2011
2	EnzymesIBA 09/2017 - 11/2002
2	Superoxides (Superoxide)IBA 01/2016 - 04/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2014 - 08/2006
2	Matrix Metalloproteinases (MMPs)IBA 10/2009 - 07/2002
2	Transforming Growth Factor beta (TGF-beta)IBA 07/2008 - 10/2005
2	AntioxidantsIBA 09/2005 - 11/2002
2	Ethanol (Ethyl Alcohol)IBA 11/2003 - 10/2002
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 11/2003 - 10/2002
1	angiogeninIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2020
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2019
1	Extracellular Matrix ProteinsIBA 01/2018
1	CalciumIBA 01/2018
1	LipidsIBA 01/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 09/2017
1	Histones (Histone)IBA 09/2017
1	Small Interfering RNA (siRNA)IBA 09/2017
1	Messenger RNA (mRNA)IBA 09/2017
1	Deubiquitinating EnzymesIBA 09/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2017
1	MART-1 AntigenIBA 09/2017
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 01/2017
1	Peroxidase (Myeloperoxidase)IBA 01/2016
1	GelatinasesIBA 01/2016
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2016
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2016
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2015
1	Imiquimod (Aldara)FDA LinkGeneric 12/2013
1	Interleukin-17 (Interleukin 17)IBA 12/2013
1	Hydroxyl RadicalIBA 03/2011
1	Oxygen (Dioxygen)IBA 09/2009
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2009
1	CollagenIBA 04/2009
1	Neutralizing AntibodiesIBA 07/2008
1	CD18 AntigensIBA 07/2008
1	ElementsIBA 04/2008
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 10/2005
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 10/2005
1	Fibronectins (Fibronectin)IBA 10/2005
1	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 10/2004
1	Phosphatidylcholines (Phosphatidylcholine)IBA 10/2004
1	ManganeseIBA 11/2002
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 07/2002
1	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 07/2002

Therapy/Procedure

8	Therapeutics 01/2022 - 11/2003
1	Transplantation 01/2020
1	Surgical Amputation (Amputations) 01/2019
1	Intradermal Injections 03/2013
1	Injections 10/2005